64 related articles for article (PubMed ID: 8096384)
1. Enhanced binding to antigen of monoclonal antibodies modified with a crosslinker.
Ueno H; Masuko T; Wang J; Hashimoto Y
Biochem Biophys Res Commun; 1993 Mar; 191(2):701-8. PubMed ID: 8096384
[TBL] [Abstract][Full Text] [Related]
2. Efficient immunostaining of tissue sections with chemically modified monoclonal antibody.
Masuko T; Ueno H; Hashimoto Y
J Immunol Methods; 1993 Sep; 165(1):67-73. PubMed ID: 7691966
[TBL] [Abstract][Full Text] [Related]
3. Epitope mapping of bovine serum albumin using monoclonal antibodies coupled with a photoreactive crosslinker.
Ueno H; Masuko T; Wang J; Hashimoto Y
J Biochem; 1994 Jun; 115(6):1119-27. PubMed ID: 7982892
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies.
Wang X; Campoli M; Ko E; Luo W; Ferrone S
J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013
[TBL] [Abstract][Full Text] [Related]
5. Influence of affinity and antigen density on antibody localization in a modifiable tumor targeting model.
Zuckier LS; Berkowitz EZ; Sattenberg RJ; Zhao QH; Deng HF; Scharff MD
Cancer Res; 2000 Dec; 60(24):7008-13. PubMed ID: 11156404
[TBL] [Abstract][Full Text] [Related]
6. Augmented binding of radiolabeled monoclonal antibodies to melanoma cells using specific antibody combinations.
Mujoo K; Rosenblum MG; Murray JL
Cancer Res; 1991 Jun; 51(11):2768-72. PubMed ID: 2032216
[TBL] [Abstract][Full Text] [Related]
7. Enzyme-linked immunosorbent assay and flow cytometric methods to screen hybridoma culture supernatants for antibodies to bovine neutrophil surface antigens, and monoclonal antibody production and characterization.
Salgar SK; Paape MJ; Alston-Mills B
Am J Vet Res; 1993 Sep; 54(9):1415-25. PubMed ID: 8239127
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody homodimers: enhanced antitumor activity in nude mice.
Wolff EA; Schreiber GJ; Cosand WL; Raff HV
Cancer Res; 1993 Jun; 53(11):2560-5. PubMed ID: 8495420
[TBL] [Abstract][Full Text] [Related]
9. Generation of monoclonal antibody CIBCgp185 against C-erbB-2 oncoprotein and its clinical evaluation.
Meenakshi A; Kumar RS; Kumar NS
Hum Antibodies; 2001; 10(3-4):101-7. PubMed ID: 11847421
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies that distinguish between two related digitalis glycosides, ouabain and digoxin.
Parhami-Seren B; Bell C; Margolies MN; Haupert GT
J Immunol; 1999 Oct; 163(8):4360-6. PubMed ID: 10510376
[TBL] [Abstract][Full Text] [Related]
11. Novel cross-linked enzyme-antibody conjugates for Western blot and ELISA.
Simons B; Kaplan H; Hefford MA
J Immunol Methods; 2006 Aug; 315(1-2):88-98. PubMed ID: 16905142
[TBL] [Abstract][Full Text] [Related]
12. Efficient immobilization of a ligand antibody with high antigen-binding activity by use of a polystyrene-binding peptide and an intelligent microtiter plate.
Kumada Y; Hamasaki K; Shiritani Y; Ohse T; Kishimoto M
J Biotechnol; 2009 Jun; 142(2):135-41. PubMed ID: 19501265
[TBL] [Abstract][Full Text] [Related]
13. Use of phage display for the generation of human antibodies that neutralize factor IXa function.
Suggett S; Kirchhofer D; Hass P; Lipari T; Moran P; Nagel M; Judice K; Schroeder K; Tom J; Lowman H; Adams C; Eaton D; Devaux B
Blood Coagul Fibrinolysis; 2000 Jan; 11(1):27-42. PubMed ID: 10691097
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the antigen binding site of anti-deoxycholate monoclonal antibody using a novel affinity labeling reagent, acyl adenylate.
Mano N; Nagaya Y; Saito S; Kobayashi N; Goto J
Biochemistry; 2004 Feb; 43(7):2041-8. PubMed ID: 14967044
[TBL] [Abstract][Full Text] [Related]
15. Compartmental distribution of tumor-specific monoclonal antibodies in human melanoma xenografts.
Lin K; Nagy JA; Xu H; Shockley TR; Yarmush ML; Dvorak HF
Cancer Res; 1994 Apr; 54(8):2269-77. PubMed ID: 8174137
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of an antigen-binding capture ELISA for native and putrescine-modified anti-tetanus F(ab')2 fragments for the assessment of the cellular uptake and plasma kinetics of the antibodies.
Welfringer F; d'Athis P; Scherrmann JM; Hervé F
J Immunol Methods; 2005 Dec; 307(1-2):82-95. PubMed ID: 16305797
[TBL] [Abstract][Full Text] [Related]
17. Construction, expression and characterization of the engineered antibody against tumor surface antigen, p185(c-erbB-2).
Cheng LS; Liu AP; Yang JH; Dong YQ; Li LW; Wang J; Wang CC; Liu J
Cell Res; 2003 Feb; 13(1):35-48. PubMed ID: 12643348
[TBL] [Abstract][Full Text] [Related]
18. Construction of an immunotoxin with the pore forming protein StI and ior C5, a monoclonal antibody against a colon cancer cell line.
Tejuca M; Díaz I; Figueredo R; Roque L; Pazos F; Martínez D; Iznaga-Escobar N; Pérez R; Alvarez C; Lanio ME
Int Immunopharmacol; 2004 Jun; 4(6):731-44. PubMed ID: 15135315
[TBL] [Abstract][Full Text] [Related]
19. Modification of liposomes with proteins by dansyl-labeled heterobifunctional crosslinker.
Chen T; Wang R; Lu T; Liang G; Lu T
J Biomater Appl; 2011 Jul; 26(1):117-25. PubMed ID: 20237178
[TBL] [Abstract][Full Text] [Related]
20. Isolation of human anti-idiotypic antibodies by phage display for clinical immune response assays.
Tornetta M; Fisher D; O'Neil K; Geng D; Schantz A; Brigham-Burke M; Lombardo D; Fink D; Knight D; Sweet R; Tsui P
J Immunol Methods; 2007 Dec; 328(1-2):34-44. PubMed ID: 17888945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
